Fampyra 10 mg Norwegen - Norwegisch - Statens legemiddelverk

fampyra 10 mg

orifarm as - fampridin - depottablett - 10 mg

Mitoxantron Ebewe 2 mg/ ml Norwegen - Norwegisch - Statens legemiddelverk

mitoxantron ebewe 2 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Novantrone 2 mg/ ml Norwegen - Norwegisch - Statens legemiddelverk

novantrone 2 mg/ ml

viatris as - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Zeposia Europäische Union - Norwegisch - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressive - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Fampridine Accord Europäische Union - Norwegisch - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Mavenclad 10 mg Norwegen - Norwegisch - Statens legemiddelverk

mavenclad 10 mg

orifarm as - kladribin - tablett - 10 mg

Fampridine Sandoz 10 mg Norwegen - Norwegisch - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg